Affiliation:
1. Heart, Mind and Body Research Group, Griffith University, Gold Coast, QLD 4222, Australia
Abstract
Flavonoids are the largest group of polyphenols, represented by many compounds that exhibit high anticancer properties. Quercetin (Q) and its main derivatives (rutin, quercitrin, isoquercitrin, isorhamnetin, tamarixetin, rhamnetin, and hyperoside) in the class of flavonols have been documented to exert anticancer activity. Q has been shown to be useful in the treatment of non-small cell lung cancer (NSCLC), as demonstrated by in vitro/in vivo studies, due to its antitumor, anti-inflammatory, anti-proliferative, anti-angiogenesis, and apoptotic properties. Some flavonoids (flavone, anthocyanins, and proanthocyanidins) have been demonstrated to be effective in nicotine-induced NSCLC treatment. However, the molecular mechanisms of quercetin derivatives (QDs) in nicotine-induced NSCLC treatment remain unclear. Thus, this review aims to summarize the available literature on the therapeutic effects of QDs in nicotine-induced NSCLC.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference79 articles.
1. Epidemiology of lung cancer;Thandra;Contemp. Oncol.,2021
2. Non-small-cell lung cancer;Gridelli;Nat. Rev. Dis. Primers,2015
3. Small-cell lung cancer;Rudin;Nat. Rev. Dis. Primers,2021
4. Carcinogenic components of tobacco and tobacco smoke: A 2022 update;Li;Food Chem. Toxicol.,2022
5. Lung Carcinogenesis by tobacco smoke;Hecht;Int. J. Cancer,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献